Cargando…

Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression

Aberrant restoration of AR activity is linked with prostate tumor growth, therapeutic failures and development of castrate-resistant prostate cancer. Understanding the processes leading to AR-reactivation should provide the foundation for novel avenues of drug discovery. A differential gene expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhowal, Ankur, Majumder, Subhadipa, Ghosh, Subarna, Basu, Sanmitra, Sen, Debrup, Roychowdhury, Susanta, Sengupta, Sanghamitra, Chatterji, Urmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575002/ https://www.ncbi.nlm.nih.gov/pubmed/28852180 http://dx.doi.org/10.1038/s41598-017-10068-9

Ejemplares similares

A Study of Molecular Signals Deregulating Mismatch Repair Genes in Prostate Cancer Compared to Benign Prostatic Hyperplasia
por: Basu, Sanmitra, et al.
Publicado: (2015)

Gene-Gene Interaction and Functional Impact of Polymorphisms on Innate Immune Genes in Controlling Plasmodium falciparum Blood Infection Level
por: Basu, Madhumita, et al.
Publicado: (2012)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
por: Janković, Miroslava M., et al.
Publicado: (2008)

Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer
por: Sarkar, Purandar, et al.
Publicado: (2022)

Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
por: Mukherjee, Pritha, et al.
Publicado: (2017)

The role of immunophilins in viral infection()
por: Hopkins, Sam, et al.
Publicado: (2015)

Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts
por: Prajapati, Akhilesh, et al.
Publicado: (2013)

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)

Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review
por: Yang, Che-Hsueh, et al.
Publicado: (2022)

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
por: Oseni, Saheed Oluwasina, et al.
Publicado: (2023)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research : an update
Publicado: (2003)

Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis
por: Zhang, Lei, et al.
Publicado: (2020)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Effects of Destruxin A on Silkworm’s Immunophilins
por: Wang, Jingjing, et al.
Publicado: (2019)

The emerging importance of immunophilins in fibrosis development
por: Alqudah, Abdelrahim, et al.
Publicado: (2022)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Mantzoros, C. S., et al.
Publicado: (1997)

Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
por: Jedinak, Andrej, et al.
Publicado: (2015)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
por: McNally, Christopher J, et al.
Publicado: (2020)

Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer
por: Tolani, Musliu Adetola, et al.
Publicado: (2020)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
por: Phua, Teow J.
Publicado: (2021)

Fibromodulin Gene Variants (FMOD) as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia
por: Silva, Tamara, et al.
Publicado: (2022)

Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia
por: SANCER, Okan, et al.
Publicado: (2022)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2023)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia
por: Saito, Shigeyoshi, et al.
Publicado: (2022)

Evaluation of Molecular Species of Prostate-Specific Antigen Complexed with Immunoglobulin M in Prostate Cancer and Benign Prostatic Hyperplasia
por: Goč, Sanja, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s2p39ii0h7qt90bo5dg159t4kk